“Based on the literature that I have read, with the more advanced and the more recent testing…the goal is to increase the efficacy of the test,” said David C. Collymore, MD, MBA. With the rapid developments seen in recent years, Collymore highlights several advantages of the newer generation tests. He thinks these tests are less expensive, they have a much faster turnaround time, and the newer tests can analyze a much bigger sample size over a much shorter duration of time. “I think those are tremendous advances in terms of making the tests more accessible to the general population,” Collymore said.
Not being familiar with the very latest developments in the field of diagnostic testing, Collymore said he cannot predict what the cutting edge developments will be in the space, “But I do know that the advances that have been made are very positive.” Indicating the need to conduct a significant number of studies that yield little or any benefit in order to get to that one study that will demonstrate significant change, he said, “Recent research has been very positive, has been able to yield greater results, and has made testing available to the general population.”
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
November 21st 2024A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Read More
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease
November 20th 2024Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.
Read More